Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease
© Williams et al; licensee BioMed Central Ltd. 2011
Received: 16 August 2010
Accepted: 24 March 2011
Published: 24 March 2011
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|16 Aug 2010||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|25 Oct 2010||Reviewed||Reviewer Report - Orestis Panagiotou|
|8 Nov 2010||Reviewed||Reviewer Report - Teresa Ferreira|
|8 Jan 2011||Author responded||Author comments - Paul Williams|
|Resubmission - Version 4|
|8 Jan 2011||Submitted||Manuscript version 4|
|21 Jan 2011||Reviewed||Reviewer Report - Orestis Panagiotou|
|25 Jan 2011||Reviewed||Reviewer Report - Teresa Ferreira|
|11 Feb 2011||Author responded||Author comments - Paul Williams|
|Resubmission - Version 5|
|11 Feb 2011||Submitted||Manuscript version 5|
|Resubmission - Version 6|
|Submitted||Manuscript version 6|
|24 Feb 2011||Author responded||Author comments - Paul Williams|
|Resubmission - Version 7|
|24 Feb 2011||Submitted||Manuscript version 7|
|24 Mar 2011||Editorially accepted|
|24 Mar 2011||Article published||10.1186/1471-2350-12-42|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.